# Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast

> **NCT03154281** · PHASE1 · COMPLETED · sponsor: **Avera McKennan Hospital & University Health Center** · enrollment: 14 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer

## Interventions

- **DRUG:** niraparib
- **DRUG:** everolimus

## Key facts

- **NCT ID:** NCT03154281
- **Lead sponsor:** Avera McKennan Hospital & University Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-26
- **Primary completion:** 2021-04-21
- **Final completion:** 2023-05-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03154281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03154281, "Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03154281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*